title: Continuous nasogastric infusion of prostaglandin E2 in ductus-dependent congenital heart disease.
authors.forename: O
authors.initials: O
authors.lastname: Komiyama
authors.forename: M
authors.initials: M
authors.lastname: Osano
authors.forename: T
authors.initials: T
authors.lastname: Oikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Morikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Kojima
authors.forename: T
authors.initials: T
authors.lastname: Murai
authors.forename: J
authors.initials: J
authors.lastname: Ishihara
authors.forename: M
authors.initials: M
authors.lastname: Tokumura
authors.forename: N
authors.initials: N
authors.lastname: Taguchi
mesh_terms: D015232:Dinoprostone / Q000008:administration & dosage*; D004374:Ductus Arteriosus, Patent / Q000503:physiopathology*; D005260:Female; D006330:Heart Defects, Congenital / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007441:Intubation, Gastrointestinal; D008297:Male; D013997:Time Factors
chemical_list: D015232:Dinoprostone